Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Persson

Showing results (151-160 of 245) with videos related to

Pageof 25
Sort By:
European Journal of Clinical Pharmacology|January 1, 1982
Effects of enprofylline, a xanthine lacking adenosine receptor antagonism, in patients with chronic obstructive lung diseaseE Lunell, N Svedmyr, K E Andersson, et al.
Annals of the New York Academy of Sciences|January 1, 1982
The role of beta-receptor agonists in the inhibition of pulmonary edemaC G Persson, I Erjefält, G J Grega, et al.
European Journal of Respiratory Diseases|July 1, 1983
A novel bronchodilator xanthine apparently without adenosine receptor antagonism and tremorogenic effectE Lunell, N Svedmyr, K E Andersson, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1977
Adrenoceptor and cholinoceptor mediated responses of the isolated human urethraA Ek, P Alm, K E Andersson, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 1, 1995
Epithelial pathways for luminal entry of bulk plasmaJ S Erjefält, I Erjefält, F Sundler, et al.
Allergy|November 1, 1993
Mucosal exudation of plasma is a noninjurious intestinal defense mechanismC G Persson, B Gustafsson, J S Erjefält, et al.
Alimentary Pharmacology & Therapeutics|December 12, 2001
Gut mucosal uptake and retention characteristics contribute to the high intestinal selectivity of budesonide compared with prednisolone in the ratA Miller-Larsson, B Gustafsson, C G Persson, et al.
European Journal of Respiratory Diseases|January 1, 1984
Intravenous enprofylline in asthma patientsE Lunell, K E Andersson, C G Persson, et al.
Agents and Actions. Supplements|January 1, 1990
Which markers of inflammation should be used in therapeutic intervention studies of CB/COAD?P Venge, R Brattsand, L A Laitinen, et al.
Life Sciences. Pt. 1: Physiology and Pharmacology|August 1, 1972
Effect of cholecystokinin on the level of cyclic AMP and on mechanical activity in the isolated sphincter of OddiK E Andersson, R Andersson, P Hedner, et al.
Pageof 25

Showing results (151-160 of 245) with videos related to

Sort By:
Pageof 25
European Journal of Clinical Pharmacology|January 1, 1982
Effects of enprofylline, a xanthine lacking adenosine receptor antagonism, in patients with chronic obstructive lung diseaseE Lunell, N Svedmyr, K E Andersson, et al.
Annals of the New York Academy of Sciences|January 1, 1982
The role of beta-receptor agonists in the inhibition of pulmonary edemaC G Persson, I Erjefält, G J Grega, et al.
European Journal of Respiratory Diseases|July 1, 1983
A novel bronchodilator xanthine apparently without adenosine receptor antagonism and tremorogenic effectE Lunell, N Svedmyr, K E Andersson, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1977
Adrenoceptor and cholinoceptor mediated responses of the isolated human urethraA Ek, P Alm, K E Andersson, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 1, 1995
Epithelial pathways for luminal entry of bulk plasmaJ S Erjefält, I Erjefält, F Sundler, et al.
Allergy|November 1, 1993
Mucosal exudation of plasma is a noninjurious intestinal defense mechanismC G Persson, B Gustafsson, J S Erjefält, et al.
Alimentary Pharmacology & Therapeutics|December 12, 2001
Gut mucosal uptake and retention characteristics contribute to the high intestinal selectivity of budesonide compared with prednisolone in the ratA Miller-Larsson, B Gustafsson, C G Persson, et al.
European Journal of Respiratory Diseases|January 1, 1984
Intravenous enprofylline in asthma patientsE Lunell, K E Andersson, C G Persson, et al.
Agents and Actions. Supplements|January 1, 1990
Which markers of inflammation should be used in therapeutic intervention studies of CB/COAD?P Venge, R Brattsand, L A Laitinen, et al.
Life Sciences. Pt. 1: Physiology and Pharmacology|August 1, 1972
Effect of cholecystokinin on the level of cyclic AMP and on mechanical activity in the isolated sphincter of OddiK E Andersson, R Andersson, P Hedner, et al.
Pageof 25